Keywords: takeda, lookout, next, blockbuster, ahead, losing, patent
Takeda on lookout for next blockbuster
Article | 23 August 2004
Ahead of losing patent protection in 2009 for its $4 billion-a-yearlead drug Prevacid (lansoprazole), Japan's Takeda is looking for a replacement, the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
